The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2024
Filed:
Sep. 29, 2020
Applicant:
Rush University Medical Center, Chicago, IL (US);
Inventor:
Kalipada Pahan, Skokie, IL (US);
Assignee:
RUSH UNIVERSITY MEDICAL CENTER, Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/616 (2006.01); A61K 31/07 (2006.01); A61K 31/192 (2006.01); A61K 31/203 (2006.01); A61K 31/216 (2006.01); A61K 31/22 (2006.01); A61K 31/222 (2006.01); A61K 31/366 (2006.01); A61K 31/40 (2006.01); A61K 31/404 (2006.01); A61K 31/47 (2006.01); A61K 31/505 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/616 (2013.01); A61K 31/07 (2013.01); A61K 31/192 (2013.01); A61K 31/203 (2013.01); A61K 31/216 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/366 (2013.01); A61K 31/40 (2013.01); A61K 31/404 (2013.01); A61K 31/47 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01);
Abstract
One aspect of the invention provides a method for treatment of a lysosomal storage disorder. The method may include administering to a subject in need of such treatment a composition including a therapeutically effective amount of an agent that mediates upregulation of Transcription Factor EB. In one embodiment, the composition includes a fibrate, such as gemfibrozil or fenofibrate. In another embodiment, the composition also includes all-trans retinoic acid or vitamin A.